Urinary Exosomes Identify Inflammatory Pathways in Vancomycin Associated Acute Kidney Injury

Background: Vancomycin is commonly used as a first line therapy for gram positive organisms such as methicillin resistant <i>Staphylococcus</i><i>aureus</i>. Vancomycin-induced acute kidney injury (V-AKI) has been reported in up to 43% of patients, especially in those with hi...

Full description

Bibliographic Details
Main Authors: Linda Awdishu, Amy Le, Jordan Amato, Vidhyut Jani, Soma Bal, Robert H. Mills, Marvic Carrillo-Terrazas, David J. Gonzalez, Ashita Tolwani, Anjali Acharya, Jorge Cerda, Melanie S. Joy, Paola Nicoletti, Etienne Macedo, Sucheta Vaingankar, Ravindra Mehta, Satish P. RamachandraRao, on behalf of the Direct Investigators
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:International Journal of Molecular Sciences
Subjects:
AKI
Online Access:https://www.mdpi.com/1422-0067/22/6/2784